ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,809, issued on June 17, was assigned to NantBio Inc. (Culver City, Calif.).
"Cellular adjuvants for viral infection" was invented by Kayvan Niazi (Culver City, Calif.), Raymond Wong (Los Angeles), Peter Sieling (Culver City, Calif.) and Philip T. Liu (Culver City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Two-component vaccine formulations and methods are contemplated where the vaccine has an adjuvant component and a therapeutic component. The therapeutic component comprises preferably a recombinant therapeutic virus encoding a therapeutic antigen while the adjuvant component comprises a non-host cell or immune stimulating portion thereo...